Lequin, Jerson V.
HRN: 26-84-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/22/2025
03/29/2025
IV
2.25gm
Q8h
Intraabdominal Infection T/c Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes